Skip to main content

Zoetis Inc. income statement

  • ZTS · NYSE
  • Pharmaceuticals
  • S&P 500
$83.82+1.04%Close 13 Nov 2026

Zoetis Inc. reported revenue of $9.47 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 2.3% from fiscal 2024. Net income was $2.67 billion and diluted earnings per share $6.02.

From Zoetis Inc.'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Zoetis Inc. income statement, annual
USDFY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$4.23B$4.34B$4.56B$4.79B$4.76B$4.89B$5.31B$5.83B$6.26B$6.67B$7.78B$8.08B$8.54B$9.26B$9.47B$9.49B
Revenue growth—+2.4%+5.2%+4.9%−0.4%+2.6%+8.6%+9.8%+7.5%+6.6%+16.5%+3.9%+5.7%+8.3%+2.3%—
Net interest income—————$8.00M$13.00M$31.00M$37.00M$12.00M$6.00M$50.00M$105.0M$106.0M$93.00M$78.00M
Cost of revenue$1.65B$1.56B$1.67B$1.72B$1.74B$1.67B$1.77B$1.91B$1.99B$2.06B$2.30B$2.45B$2.56B$2.72B$2.67B$2.70B
Gross profit$2.58B$2.77B$2.89B$3.07B$3.03B$3.22B$3.53B$3.91B$4.27B$4.62B$5.47B$5.63B$5.98B$6.54B$6.80B$6.79B
Gross margin61.0%64.0%63.4%64.1%63.5%65.9%66.6%67.2%68.2%69.2%70.4%69.6%70.0%70.6%71.8%71.6%
Selling, general and administrative$1.45B$1.47B$1.61B$1.64B$1.53B$1.36B$1.33B$1.48B$1.64B$1.73B$2.00B$2.01B$2.15B$2.32B$2.38B$2.37B
Operating income$430.0M$741.0M$803.0M$937.0M$669.0M$1.39B$1.71B$1.81B$1.97B$2.24B$2.76B$2.92B$3.02B$3.34B$3.55B$3.42B
Operating margin10.2%17.1%17.6%19.6%14.0%28.5%32.1%31.1%31.4%33.6%35.5%36.1%35.3%36.1%37.5%36.0%
Interest expense$36.00M$31.00M$113.0M$117.0M$124.0M$166.0M$175.0M$206.0M$223.0M$231.0M$224.0M$221.0M$239.0M$225.0M$222.0M$242.0M
Other income and expense−$48.00M$46.00M$9.00M−$7.00M−$81.00M$2.00M−$6.00M$83.00M$57.00M−$17.00M−$48.00M−$40.00M$159.0M$19.00M$36.00M−$36.00M
Income before tax$394.0M$710.0M$690.0M$820.0M$545.0M$1.23B$1.52B$1.69B$1.80B$2.00B$2.49B$2.66B$2.94B$3.13B$3.36B$3.14B
Income tax expense$146.0M$274.0M$187.0M$233.0M$206.0M$409.0M$663.0M$266.0M$301.0M$360.0M$454.0M$545.0M$596.0M$637.0M$687.0M$635.0M
Effective tax rate37.1%38.6%27.1%28.4%37.8%33.3%43.5%15.7%16.7%18.0%18.2%20.5%20.3%20.3%20.4%20.2%
Net income$245.0M$436.0M$504.0M$583.0M$339.0M$821.0M$864.0M$1.43B$1.50B$1.64B$2.04B$2.11B$2.34B$2.49B$2.67B$2.51B
Net margin5.8%10.1%11.1%12.2%7.1%16.8%16.3%24.5%24.0%24.5%26.2%26.2%27.4%26.9%28.2%26.4%
EPS · diluted$0.49$0.87$1.01$1.16$0.68$1.65$1.75$2.93$3.11$3.42$4.27$4.49$5.07$5.47$6.02$5.93
Diluted weighted average shares500M500M500M502M502M498M493M487M482M479M477M470M462M455M444M423M
Basic weighted average shares500M500M500M501M500M496M490M483M478M476M474M469M461M454M443M422M
EBITDA$635.0M$941.0M$1.01B$1.14B$868.0M$1.63B$1.95B$2.12B$2.38B$2.69B$3.21B$3.38B$3.51B$3.84B$4.03B$3.90B
EBITDA margin15.0%21.7%22.2%23.8%18.2%33.4%36.7%36.4%38.0%40.2%41.3%41.9%41.0%41.4%42.6%41.1%
Depreciation & amortization$205.0M$200.0M$209.0M$204.0M$199.0M$240.0M$242.0M$308.0M$412.0M$441.0M$448.0M$465.0M$491.0M$497.0M$487.0M$479.0M
Stock-based compensation$19.00M$28.00M$43.00M$32.00M$43.00M$37.00M$44.00M$53.00M$67.00M$59.00M$58.00M$62.00M$60.00M$74.00M$83.00M$100.0M
Dividends per share$0.00$0.00$0.27$0.30$0.34$0.39$0.44$0.54$0.69$0.85$1.07$1.35$1.56$1.80$2.03—

Quarterly

Zoetis Inc. income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$2.21B$2.19B$2.36B$2.39B$2.32B$2.20B$2.47B$2.42B$2.37B$2.26B$2.47B$2.39B
Net interest income$26.00M$32.00M$24.00M$23.00M$27.00M$22.00M$20.00M$27.00M$24.00M$21.00M$16.00M$17.00M
Cost of revenue$728.0M$643.0M$668.0M$701.0M$707.0M$618.0M$664.0M$697.0M$687.0M$641.0M$673.0M$698.0M
Gross profit$1.49B$1.55B$1.69B$1.69B$1.61B$1.58B$1.81B$1.73B$1.69B$1.62B$1.79B$1.69B
Gross margin67.1%70.6%71.7%70.6%69.5%71.9%73.2%71.2%71.0%71.7%72.7%70.8%
Selling, general and administrative$565.0M$547.0M$581.0M$565.0M$625.0M$574.0M$614.0M$582.0M$608.0M$588.0M$592.0M$582.0M
Operating income$701.0M$797.0M$864.0M$915.0M$763.0M$812.0M$967.0M$932.0M$835.0M$800.0M$922.0M$863.0M
Operating margin31.7%36.4%36.6%38.3%32.9%36.9%39.1%38.5%35.2%35.4%37.4%36.1%
Interest expense$59.00M$58.00M$59.00M$57.00M$51.00M$54.00M$53.00M$58.00M$57.00M$62.00M$61.00M$62.00M
Other income and expense$8.00M$8.00M−$25.00M$16.00M$20.00M$15.00M−$2.00M$12.00M$11.00M$20.00M$5.00M−$72.00M
Income before tax$650.0M$747.0M$780.0M$874.0M$732.0M$773.0M$912.0M$886.0M$789.0M$758.0M$866.0M$729.0M
Income tax expense$127.0M$148.0M$156.0M$182.0M$151.0M$171.0M$186.0M$165.0M$165.0M$157.0M$175.0M$138.0M
Effective tax rate19.5%19.8%20.0%20.8%20.6%22.1%20.4%18.6%20.9%20.7%20.2%18.9%
Net income$525.0M$599.0M$624.0M$682.0M$581.0M$602.0M$726.0M$721.0M$624.0M$601.0M$691.0M$591.0M
Net margin23.7%27.4%26.4%28.6%25.1%27.4%29.3%29.8%26.3%26.6%28.0%24.7%
EPS · diluted$1.14$1.31$1.37$1.50$1.29$1.34$1.63$1.63$1.42$1.42$1.65$1.44
Diluted weighted average shares460M459M456M454M451M448M446M443M439M422M418M412M
Basic weighted average shares459M458M456M453M451M448M445M443M438M422M418M412M
EBITDA$827.0M$923.0M$991.0M$1.04B$886.0M$931.0M$1.09B$1.05B$957.0M$919.0M$1.04B$982.0M
EBITDA margin37.4%42.1%42.0%43.4%38.2%42.4%44.1%43.5%40.3%40.6%42.2%41.1%
Depreciation & amortization$126.0M$126.0M$127.0M$121.0M$123.0M$119.0M$124.0M$122.0M$122.0M$119.0M$119.0M$119.0M
Stock-based compensation$17.00M$18.00M$19.00M$18.00M$19.00M$17.00M$22.00M$22.00M$22.00M$25.00M$26.00M$27.00M
Dividends per share—————————$0.53$0.53$0.00

The main figures as JSON and plain text. See data and methodology.

ZTS in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.